Skip to main content
Clinical Trials/JPRN-UMIN000026645
JPRN-UMIN000026645
Completed
Phase 2

A Clinical Study to Evaluate the Efficacy and Safety of JR-031 in Patients with Epidermolysis Bullosa - A Clinical Study to Evaluate the Efficacy and Safety of JR-031 in Patients with Epidermolysis Bullosa

Osaka University0 sites6 target enrollmentMarch 24, 2017

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Epidermolysis Bullosa
Sponsor
Osaka University
Enrollment
6
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 24, 2017
End Date
June 28, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients who received a therapy with mesenchymal stem cell derived from human bone marrow or TEMUCELL HS injection. 2\) Patients who are suffering from serious mental diseases. 3\) Patients who are suffering from cancer or who have histories of suffering from cancer within 5 years prior to enrollment. 4\) Patients who are pregnant or probably pregnant. 5\) Patients who do not agree to take effective contraceptive measures during the study period. 6\) Patients who have entered other clinical trials within 6 months prior to enrollment.

Outcomes

Primary Outcomes

Not specified

Similar Trials